There is a great deal of variability in how a patient responds to medications due to the genes that govern drug metabolism, and this can therefore impact drug efficacy. Pharmacogenomics empowers the doctor to provide specific medical interventions, based on the patient’s genetic profile, and replaces the current trial and error approach to drug therapy.

mypsychRx analyses genetic variants that affect the metabolism of psychotropic medications such as:

  • Antiaddictives
  • Anti-ADHD Agents
  • Anticonvulsants
  • Antidementia Agents
  • Antidepressants
  • Antipsychotics
  • Benzodiazepines
  • Mood Stabilizers


Click here for the full list of medications reported on in mypsychRx


Benefits of pharmacogenomic testing include

  • Improve efficacy of treatment, improved quality of life for the patient
  • Decrease treatment time
  • Save money on ineffective medications
  • Patients avoid unpleasant or possible fatal side effects of some medications